gms | German Medical Science

58. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e. V. (DGNC)

Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.

26. bis 29.04.2007, Leipzig

Reliability of neuroendoscopic treatment in aqueductal stenosis related hydrocephalus

Zuverlässigkeit neuroendoskopischer Therapieverfahren beim Hydrozephalus mit Aqueduktstenose

Meeting Abstract

  • corresponding author J. Baldauf - Klinik für Neurochirurgie, Ernst-Moritz-Arndt-Universität Greifswald
  • J. Oertel - Neurochirurgische Klinik, Krankenhaus Nordstadt, Hannover
  • M. R. Gaab - Neurochirurgische Klinik, Krankenhaus Nordstadt, Hannover
  • H. W. S. Schroeder - Klinik für Neurochirurgie, Ernst-Moritz-Arndt-Universität Greifswald

Deutsche Gesellschaft für Neurochirurgie. 58. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e.V. (DGNC). Leipzig, 26.-29.04.2007. Düsseldorf: German Medical Science GMS Publishing House; 2007. DocDO.03.06

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/dgnc2007/07dgnc024.shtml

Veröffentlicht: 11. April 2007

© 2007 Baldauf et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective: Various neuroendoscopic techniques have been described for the treatment of hydrocephalus caused by aqueductal stenosis. The question was asked whether aqueductoplasty (AP) or third ventriculostomy (ETV) is more reliable in this setting.

Methods: Since 1993 69 patients with primary aqueduct stenosis have been treated with neuroendoscopy at our institution. Aqueductoplasty (group I) was performed in 20 and ETV (group II) in 36 patients. Both procedures (group III) were simultaneously done in 13 patients. The average age was 43.8 (group I), 36.6 (group II) and 33.2 (group III).

Results: There was a mean follow-up period of 36.3, 46.2 and 29.3 months (I-III). In group I, eight patients presented with restenosis of the aqueduct. Eight ETV and five Re-AP were performed in these patients. In five patients of Group II, a restenosis of the aqueduct or ventriculostoma was found. In this group three Re-ETV’s were performed. Group III verified a reclosure rate of the stoma in 11.1% (4 patients). Again, Re-ETV’s were done. There was a need for shunt implantation in 5.7% of all patients (I: 0; II: 3; III: 1).

Conclusions: There was a higher rate of restenosis of the aqueduct after AP than of the ventriculostoma after ETV. Therefore, we recommend performing ETV instead of AP in patients with hydrocephalus caused by aqueduct stenosis.